MERCK & CO., INC. (MRK)
Clinical trial NCT04736706 updates: 1. completion date: 2026-10-29 → 2027-04-22 2. primary completion date: 2026-10-29 → 2026-02-04 3. enrollment: 1653 → 1854 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04736706 updates: 1. completion date: 2026-10-29 → 2027-04-22 2. primary completion date: 2026-10-29 → 2026-02-04 3. enrollment: 1653 → 1854 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical